MiR-93 targets the AICDA 3′-UTR and would regulate AID expression in activated B cells, as it does in the MCF7 breast cancer cell line (82), which, like several cancer cell lines, expresses elevated levels of AID, a potent DNA mutator and tumorigenesis factor (83). Here, AICDA is linked to breast carcinoma.